Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,351
datasets available to search
ShareScore release 0.9.0
Dataset results
1,351 results for “Intermediates”
Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)
ClinicalTrials.gov study NCT00890006. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observation Study: Superselective Drug-Eluting Chemoembolization in Unresectable Intermediate and Advanced HCC Patients
ClinicalTrials.gov study NCT03273608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Standard Intensive Chemotherapy Versus Intensive Chemotherapy With CPX-351 in Adult Patients With Newly Diagnosed AML and Intermediate- or Adverse Genetics
ClinicalTrials.gov study NCT03897127. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
ClinicalTrials.gov study NCT03410615. IPD Sharing: NO. Countries: 4. Publications: 0.
Nonhealing Diabetic Foot Ulcers Treated With Standard of Care (SOC) Alone or Standard of Care and Amnion-Intermediate-Chorion (AIC)
ClinicalTrials.gov study NCT07014176. IPD Sharing: NO. Countries: 1. Publications: 0.
Pilot Study of a Fluocinolone Acetonide Intravitreal Insert (FA-i) to Treat Intermediate-, Posterior-, or Panuveitis
ClinicalTrials.gov study NCT01781936. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Prospective Clinical Study Using an Artery-first Intermediate Approach in Robot-assisted Pancreaticoduodenectomy
ClinicalTrials.gov study NCT05660915. IPD Sharing: NO. Countries: 1. Publications: 0.
Post-marketing Surveillance Study of Adalimumab (Humira®) for Non-infectious Intermediate, Posterior, or Panuveitis Patients
ClinicalTrials.gov study NCT03339102. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Risk of CYP2C19 Phenoconversion in Healthy Volunteers With Rapid, Normal, and Intermediate Predicted Metabolizers' Status
ClinicalTrials.gov study NCT05264142. IPD Sharing: NO. Countries: 1. Publications: 0.
Lomustine and Intermediate Dose Cytarabine in Older Patients With AML
ClinicalTrials.gov study NCT00480064. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HLA-mismatched MST vs HLA-matched NST for AML in Intermediate-risk
ClinicalTrials.gov study NCT02461121. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prospective Evaluation of Near and Intermediate Visual Outcomes With Monofocal Intraocular Lenses: The Mast Study
ClinicalTrials.gov study NCT01191515. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Efficacy of Chimeric Antigen Receptor T Lymphocytes for Patients With Intermediate and Advanced Tumors
ClinicalTrials.gov study NCT05117138. IPD Sharing: NO. Countries: 1. Publications: 0.
A Pan-Canadian, Investigator Initiated Clinical Trial With Focal IRE Directed to Intermediate-Risk Prostate Cancer
ClinicalTrials.gov study NCT06451445. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Scheduled Intravesical Gemcitabine Versus Intravesical BCG for Intermediate and High Risk Non Muscle Invasive Bladder Cancer: A Prospective, Randomized Study
ClinicalTrials.gov study NCT05626101. IPD Sharing: NO. Countries: 1. Publications: 0.
HAIC in Combination with PD-1 Inhibitors and Lenvatinib for Intermediate and Advanced HCC After the Failure of Systemic Therapy Recommended by BCLC
ClinicalTrials.gov study NCT06632093. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Posterior Extra-fascial RARP in Intermediate or High Risk Prostate Cancer
ClinicalTrials.gov study NCT06434649. IPD Sharing: NO. Countries: 1. Publications: 0.
Observation of Outcomes and Side Effects of Cesium-131 in Combination With External Beam Radiation for the Treatment of Intermediate to High Risk Prostate Cancer
ClinicalTrials.gov study NCT00621413. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Donor Cellular Therapy After Cytarabine in Treating Patients With Intermediate-Risk Acute Myeloid Leukemia in Remission
ClinicalTrials.gov study NCT02587871. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Impact of Humira® Therapy on Ocular Inflammation, Selected Health Care Resource Utilization and Patient Reported Outcomes in Patients With Active Non-infectious Intermediate, Posterior and Panuveitis
ClinicalTrials.gov study NCT03155243. IPD Sharing: UNDECIDED. Countries: 12. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.